Chiu‐Fung Tsang

Chinese University of Hong Kong

Papers

1

Total Citations

3

H-Index

1

About

Dr. Chiu‐Fung Tsang is a urologic oncologist whose research centers on prostate cancer outcomes, particularly in Asian populations where long-term data remain scarce. His landmark 2022 study, “Outcomes of radical prostatectomy in a 20-year localized prostate cancer single institution series in China,” provides crucial insights into the prognostic value of pathological and surgical factors following radical prostatectomy. Drawing from a retrospective analysis spanning over two decades, this work addresses a critical gap in understanding survival outcomes for Chinese prostate cancer patients, offering evidence that helps tailor treatment strategies in this demographic. While his most-cited paper has garnered 3 citations to date, its significance lies in establishing a foundational dataset for a region historically underrepresented in prostate cancer research. Dr. Tsang’s contributions advance the field by bridging the knowledge gap between Western and Asian clinical experiences, ultimately informing more personalized surgical decision-making. His ongoing work continues to shape the landscape of urologic oncology in China, with implications for global prostate cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Outcomes of radical prostatectomy in a 20-year localized prostate cancer single institution series in China
3 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Chinese University of Hong Kong

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago